Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    November 2017
  1. TROTTER PB, Summers DM, Ushiro-Lumb I, Robb M, et al
    Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002033.
    PubMed     Text format     Abstract available


  2. AGARWAL N, Davis RJ, Gracey DM, Wong G, et al
    Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002034.
    PubMed     Text format    


  3. HOLSCHER CM, Durand CM, Desai NM
    Expanding the Use of Organs from Hepatitis C-Viremic Donors: The Evidence Continues to Build.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002032.
    PubMed     Text format    


  4. KAMAR N, Del Bello A, Izopet J
    Should persistent hepatitis E virus replication in transplant patients be tolerated?
    Transplantation. 2017 Nov 10. doi: 10.1097/TP.0000000000001994.
    PubMed     Text format    


    October 2017
  5. HEO NY, Mannalithara A, Kim D, Udompap P, et al
    Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.
    Transplantation. 2017 Oct 3. doi: 10.1097/TP.0000000000001953.
    PubMed     Text format     Abstract available


    September 2017
  6. RADHAKRISHNAN K, Chi A, Quan DJ, Roberts JP, et al
    Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Transplantation. 2017;101:2079-2082.
    PubMed     Text format     Abstract available


    August 2017
  7. ANTONINI TM, Coilly A, Rossignol E, Fougerou-Leurent C, et al
    Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928.
    PubMed     Text format     Abstract available


  8. CHOLANKERIL G, Li AA, Yoo ER, Ahmed A, et al
    Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001926.
    PubMed     Text format    


  9. GARCIA CR, Acosta LF, Mei X, Berger J, et al
    Liver Transplantation for the Treatment of Complicated Iatrogenic Biliary Injuries: A National Review from the UNOS Dataset.
    Transplantation. 2017 Aug 22. doi: 10.1097/TP.0000000000001922.
    PubMed     Text format     Abstract available


  10. ABAALKHAIL F, Elsiesy H, Elbeshbeshy H, Shawkat M, et al
    Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001907.
    PubMed     Text format     Abstract available


  11. MCPHERSON S, Elsharkawy AM, Ankcorn M, Ijaz S, et al
    Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001908.
    PubMed     Text format     Abstract available


    July 2017
  12. FUNG J, Wong T, Chok K, Chan A, et al
    Oral nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B with Preexisting rt204 Mutation.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001883.
    PubMed     Text format     Abstract available


  13. WALLER KMJ, Wyburn KR, Shackel NA, O'Leary MJ, et al
    Hepatitis transmission risk in kidney transplantation (the HINT study): a cross-sectional survey of transplant clinicians in Australian and New Zealand.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001885.
    PubMed     Text format     Abstract available


  14. PRUETT TL, Clark MA, Taranto SE
    Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Transplantation. 2017;101:1670-1678.
    PubMed     Text format     Abstract available


  15. VOLK ML, Wilk AR, Wolfe C, Kaul DR, et al
    The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Transplantation. 2017;101:1666-1669.
    PubMed     Text format     Abstract available


    June 2017
  16. MASUTANI K, Omoto K, Okumi M, Okabe Y, et al
    Incidence of Hepatitis B Viral Reactivation After Kidney Transplantation With Low-dose Rituximab Administration.
    Transplantation. 2017 Jun 29. doi: 10.1097/TP.0000000000001870.
    PubMed     Text format     Abstract available


    May 2017

  17. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study: Erratum.
    Transplantation. 2017;101:e193.
    PubMed     Text format    


  18. SINGH N, Dies D, Samant H
    Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Transplantation. 2017;101:e192.
    PubMed     Text format    


  19. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed     Text format    


  20. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed     Text format    


  21. TAPPER EB, Afdhal NH, Curry MP
    Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
    Transplantation. 2017;101:933-937.
    PubMed     Text format     Abstract available


    April 2017
  22. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Text format     Abstract available


  23. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    PubMed     Text format     Abstract available


    March 2017
  24. TERRAULT N, Berenguer M, Strasser S, Gadano A, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001704.
    PubMed     Text format    


  25. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001708.
    PubMed     Text format    


  26. ARONSOHN A
    Timing is Everything: Managing Hepatitis C in Liver Transplant Candidates.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001703.
    PubMed     Text format    


    February 2017
  27. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    PubMed     Text format     Abstract available


  28. SANTOS AH JR, Casey MJ, Xuerong W, Womer KL, et al
    Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Transplantation. 2017;101:377-386.
    PubMed     Text format     Abstract available


    January 2017
  29. HIRATA Y, Yoshizawa A, Egawa H, Ueda D, et al
    Impact of Antibodies that React with Liver Tissue and Donor-specific anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.
    Transplantation. 2017 Jan 23. doi: 10.1097/TP.0000000000001653.
    PubMed     Text format     Abstract available


  30. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available



  31. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    


    December 2016
  32. DEBES JD, de Knegt RJ, Boonstra A
    The path to cancer, and back: Immune modulation during hepatitis C virus infection, progression to fibrosis and cancer, and unexpected roles of new antivirals.
    Transplantation. 2016 Dec 30. doi: 10.1097/TP.0000000000001623.
    PubMed     Text format     Abstract available


  33. LUBETZKY M, Chun S, Joelson A, Coco M, et al
    Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001618.
    PubMed     Text format     Abstract available


  34. WERNER JM, Adenugba A, Protzer U
    Immune reconstitution following HCV clearance with direct antiviral agents: potential consequences for patients with HCC?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  35. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  36. CARRILLO CF, Crespo G, de la Revilla J, Castells L, et al
    Successful continuation of HCV treatment following liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  37. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


    November 2016
  38. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


    September 2016
  39. ELFEKI M, Abou Mrad R, Modaresi Esfeh J, Zein N, et al
    Sofosbuvir/Ledipasvir without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence after Liver Transplantation: Two-Center Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    August 2016
  40. EISENBERGER U, Guberina H, Willuweit K, Bienholz A, et al
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  41. D S, N P, B A, Rd B, et al
    Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  42. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  43. SAWINSKI D, Lee DH, Doyle AM, Blumberg EA, et al
    Successful Posttransplant Treatment of Hepatitis C with Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  44. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    March 2016
  45. DE SIMONE P, Romagnoli R, Tandoi F, Carrai P, et al
    Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  46. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  47. FAISAL N, Bilodeau M, Aljudaibi B, Hirsch G, et al
    Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  48. WATANABE M, Lundgren T, Saito Y, Cerami A, et al
    A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets.
    Transplantation. 2016;100:554-62.
    PubMed     Text format     Abstract available


    February 2016
  49. WERNER JM, Vermehren J
    New HCV Therapies and Liver Transplantation.
    Transplantation. 2016;100:260-1.
    PubMed     Text format    


    December 2015
  50. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  51. ABERG F, Nordin A, Toivonen L, Isoniemi H, et al
    Early Predictors of Long-term Outcomes of HCV-Negative Liver Transplant Recipients Having Survived the First Postoperative Year.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    October 2015
  52. EDMUNDS C, Ekong UD
    Autoimmune Liver Disease Post Liver Transplantation-A Summary and Proposed Areas for Future Research.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    July 2015
  53. LOCKE JE, Durand C, Reed RD, MacLennan PA, et al
    Long-Term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    June 2015
  54. SHAPIRO AM
    Donor-Specific Antibody in Pediatric Liver Transplantation-Identifying a Tree by its Fruit.
    Transplantation. 2015.
    PubMed     Text format    


  55. WOZNIAK LJ, Hickey MJ, Venick RS, Vargas JH, et al
    Donor-Specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: